Be among the first to access Mavatar Discovery, our groundbreaking self-service platform designed for pharmaceutical companies, CROs, researchers, and academia. While our closed beta is already in motion, we’re now opening up a waiting list for those who want early access once we expand.

Mavatar Discovery unlocks deep, integrated network analysis of disease mechanisms—across genes, cells, and signaling pathways—powered by massive amounts of public OMIC data.
‍
It’s a complete, cloud-based solution that transforms months of research into minutes of actionable insights—ready to use from day one.
‍

·  Be first in line – Get prioritized access when we launch beyond the closed beta.
· Discover faster – Leverage curated, actionable insights without the need for complex setup.
· Shape what’s next – Early users will have the opportunity to influence how the platform evolves.
‍

An integrated platform that turns overwhelming amounts of biological data into clear, research-ready insights—removing the manual effort and accelerating your path to discovery
‍

Join our waiting list to stay informed and get priority access as we roll out Mavatar Discovery to more users.
‍
‍

Download our one pager for more indepth information about Mavatar Discovery